Prolonged and exaggerated elevations in plasma thyrotropin (HTSH) after thyroptropin releasing factor (TRF) in patients with pituitary tumors.
D000172:Acromegaly / Q000097:blood; D000238:Adenoma, Chromophobe / Q000097:blood* / Q000150:complications; D003397:Craniopharyngioma / Q000097:blood*; D005260:Female; D006801:Humans; D007037:Hypothyroidism / Q000097:blood / Q000150:complications; D007275:Injections, Intravenous; D007456:Iodine Isotopes; D008297:Male; D009230:Myxedema / Q000097:blood; D010911:Pituitary Neoplasms / Q000097:blood* / Q000150:complications; D011863:Radioimmunoassay; D013972:Thyrotropin / Q000097:blood*; D013973:Thyrotropin-Releasing Hormone / Q000008:administration & dosage / Q000494:pharmacology*
D007456:Iodine Isotopes; D013973:Thyrotropin-Releasing Hormone; D013972:Thyrotropin